- Home
- ABLV vs FBIO Comparison
ABLV vs FBIO Comparison
Compare ABLV & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- FBIO
- Stock Information
- Founded
- ABLV 2015
- FBIO 2006
- Country
- ABLV China
- FBIO United States
- Employees
- ABLV N/A
- FBIO N/A
- Industry
- ABLV
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ABLV
- FBIO Health Care
- Exchange
- ABLV Nasdaq
- FBIO Nasdaq
- Market Cap
- ABLV 47.3M
- FBIO 49.1M
- IPO Year
- ABLV N/A
- FBIO N/A
- Fundamental
- Price
- ABLV $1.36
- FBIO $1.64
- Analyst Decision
- ABLV
- FBIO Strong Buy
- Analyst Count
- ABLV 0
- FBIO 3
- Target Price
- ABLV N/A
- FBIO $21.00
- AVG Volume (30 Days)
- ABLV 20.0K
- FBIO 146.2K
- Earning Date
- ABLV 01-01-0001
- FBIO 05-19-2025
- Dividend Yield
- ABLV N/A
- FBIO N/A
- EPS Growth
- ABLV N/A
- FBIO N/A
- EPS
- ABLV N/A
- FBIO N/A
- Revenue
- ABLV $128,932,647.00
- FBIO $57,675,000.00
- Revenue This Year
- ABLV N/A
- FBIO $63.20
- Revenue Next Year
- ABLV N/A
- FBIO $66.70
- P/E Ratio
- ABLV N/A
- FBIO N/A
- Revenue Growth
- ABLV N/A
- FBIO N/A
- 52 Week Low
- ABLV $0.55
- FBIO $1.33
- 52 Week High
- ABLV $1.98
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- ABLV 63.85
- FBIO 55.40
- Support Level
- ABLV $1.26
- FBIO $1.65
- Resistance Level
- ABLV $1.39
- FBIO $1.84
- Average True Range (ATR)
- ABLV 0.14
- FBIO 0.09
- MACD
- ABLV 0.02
- FBIO 0.01
- Stochastic Oscillator
- ABLV 88.89
- FBIO 65.85
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.